Clinical Trials
11 trialsNCT03003520 2023-05-22
A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma
Celgene
Phase 2 Completed
NCT00057811 2014-09-19
Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma
Children's Oncology Group
Phase 2 Completed
NCT00002590 2014-07-24
Combination Chemotherapy in Treating Children With Lymphoma
Children's Oncology Group
Phase 2 Completed
NCT00002618 2014-07-24
Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma
Children's Oncology Group
Phase 3 Completed
NCT00002757 2014-07-24
TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma
Children's Oncology Group
Phase 3 Completed
NCT00799136 2013-09-12
CATCH
Ontario Clinical Oncology Group (OCOG)
Phase 2 Completed
NCT00002691 2013-06-25
Combination Chemotherapy in Treating Pediatric Patients With Stage III or IV Non-Hodgkin's Lymphoma
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00002471 2013-06-20
Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00018954 2012-02-20
Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's Lymphoma
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00187161 2008-06-04
Treatment of Burkitt Lymphoma/Leukemia and B Large Cell NHL
St. Jude Children's Research Hospital
Phase 2 Completed
NCT00187070 2008-05-07
Large Cell Lymphoma Pilot Study III
St. Jude Children's Research Hospital
Phase NA Completed